Key Takeaways
- • Ironleaf Capital, a technology-focused healthcare private equity firm founded in 2025 by former Veritas Capital and Abry Partners partner T.J. Rose, has completed its inaugural investment in Healthcare Control Systems (HCS), according to a Business Wire release.
- • HCS, founded in 2008, provides hospitals and health systems with execution-level coordination of personnel, clinical resources and departments through its ORControl platform.
- • HCS technology is deployed at Ascension, CommonSpirit, HCA and the Veterans Health Administration across the United States and Europe.
- • Terms of the transaction were not disclosed.
- • Ironleaf plans to fund commercial organization build-out and AI-driven product innovation, with co-founder and CEO Dr. Tom Feo continuing to lead the company.
Summary
Ironleaf Capital ("Ironleaf") announced that it has completed a strategic investment in Healthcare Control Systems ("HCS"), according to a Business Wire release issued from New York and Austin, Texas. Ironleaf describes itself as a specialized, technology-focused healthcare private equity firm that invests in lower-middle-market privately held and founder-owned companies seeking to improve the efficiency, cost and quality of healthcare. The firm was founded in 2025 by T.J. Rose, a former partner at Veritas Capital and Abry Partners, and uses what it calls its SCALE Method value creation framework. Terms of the transaction were not disclosed.
HCS, founded in 2008, provides hospitals and health systems with what the company describes as comprehensive execution-level coordination of personnel, clinical resources and departments. Its flagship product, ORControl, integrates disparate hospital IT systems and departmental workflows to give teams real-time situational awareness, manage staff and room utilization, coordinate patient care and automatically adjust schedules. The company says its technology is deployed across many leading hospitals in the United States and Europe, including Ascension, CommonSpirit, HCA and the Veterans Health Administration. The company asserts that its platform improves hospital-wide efficiency, clinical productivity and patient satisfaction scores; these are company claims rather than independently verified results.
Under the deal, Ironleaf will partner with HCS's founders, including Co-Founder and CEO Dr. Tom Feo, and the existing management team. Rose said HCS fits the firm's investment thesis and that Ironleaf will help the HCS team build out its commercial organization and accelerate AI-driven product innovation. Dr. Feo said the Ironleaf team's experience scaling technology-enabled healthcare businesses makes it the right partner for continued growth, with plans to expand availability of the technology to additional hospitals and health systems in the United States and Europe.
McDermott Will & Schulte LLP acted as legal counsel to Ironleaf, Bridgepoint served as financial advisor, and Vacek, Kiecke & Colmenero, LLP served as legal counsel to HCS.
HCS, founded in 2008, provides hospitals and health systems with what the company describes as comprehensive execution-level coordination of personnel, clinical resources and departments. Its flagship product, ORControl, integrates disparate hospital IT systems and departmental workflows to give teams real-time situational awareness, manage staff and room utilization, coordinate patient care and automatically adjust schedules. The company says its technology is deployed across many leading hospitals in the United States and Europe, including Ascension, CommonSpirit, HCA and the Veterans Health Administration. The company asserts that its platform improves hospital-wide efficiency, clinical productivity and patient satisfaction scores; these are company claims rather than independently verified results.
Under the deal, Ironleaf will partner with HCS's founders, including Co-Founder and CEO Dr. Tom Feo, and the existing management team. Rose said HCS fits the firm's investment thesis and that Ironleaf will help the HCS team build out its commercial organization and accelerate AI-driven product innovation. Dr. Feo said the Ironleaf team's experience scaling technology-enabled healthcare businesses makes it the right partner for continued growth, with plans to expand availability of the technology to additional hospitals and health systems in the United States and Europe.
McDermott Will & Schulte LLP acted as legal counsel to Ironleaf, Bridgepoint served as financial advisor, and Vacek, Kiecke & Colmenero, LLP served as legal counsel to HCS.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.